Christine Lawson

University of California San Diego — United States

Medicine · Health Sciences

25h-index2.3kcitations73works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cell Adhesion Molecules Research(39), Protease and Inhibitor Mechanisms(14), Cellular Mechanics and Interactions(8), Caveolin-1 and cellular processes(8), Immunotherapy and Immune Responses(7)

Publications73 total

FAK inhibition in ovarian cancer releases omega-3 fatty acids to program CXCL13-producing anti-tumor resident peritoneal macrophages
Cell Reports·2026Open Access
Ovarian Tumor FAK Inhibition Releases Omega-3 Fatty Acids Stimulating GATA6 Peritoneal Macrophage CXCL13 Production Enhancing Immunotherapy
2025Open Access
Norepinephrine versus epinephrine for hemodynamic support in post-cardiac arrest shock: A systematic review
The American Journal of Emergency Medicine·2023· 7 cited
Intratumoral administration of unconjugated Accum™ impairs the growth of pre‐established solid lymphoma tumors
Cancer Science·2023· 8 citedOpen Access
Supplementary Table 2 from FAK Inhibition Disrupts a β5 Integrin Signaling Axis Controlling Anchorage-Independent Ovarian Carcinoma Growth
2023Open Access
Supplementary Figure 3 from FAK Inhibition Disrupts a β5 Integrin Signaling Axis Controlling Anchorage-Independent Ovarian Carcinoma Growth
2023Open Access
Supplementary Figure 5 from FAK Inhibition Disrupts a β5 Integrin Signaling Axis Controlling Anchorage-Independent Ovarian Carcinoma Growth
2023Open Access
Data from FAK Inhibition Disrupts a β5 Integrin Signaling Axis Controlling Anchorage-Independent Ovarian Carcinoma Growth
2023Open Access
Supplementary Methods from FAK Inhibition Disrupts a β5 Integrin Signaling Axis Controlling Anchorage-Independent Ovarian Carcinoma Growth
2023Open Access
Supplementary Figure 4 from FAK Inhibition Disrupts a β5 Integrin Signaling Axis Controlling Anchorage-Independent Ovarian Carcinoma Growth
2023Open Access
Supplementary Figure 3 from FAK Inhibition Disrupts a β5 Integrin Signaling Axis Controlling Anchorage-Independent Ovarian Carcinoma Growth
2023Open Access
Supplementary Methods from FAK Inhibition Disrupts a β5 Integrin Signaling Axis Controlling Anchorage-Independent Ovarian Carcinoma Growth
2023Open Access
Supplementary Figure 1 from FAK Inhibition Disrupts a β5 Integrin Signaling Axis Controlling Anchorage-Independent Ovarian Carcinoma Growth
2023Open Access
Supplementary Figure 4 from FAK Inhibition Disrupts a β5 Integrin Signaling Axis Controlling Anchorage-Independent Ovarian Carcinoma Growth
2023Open Access
Supplementary Table 2 from FAK Inhibition Disrupts a β5 Integrin Signaling Axis Controlling Anchorage-Independent Ovarian Carcinoma Growth
2023Open Access
Supplementary Table 1 from FAK Inhibition Disrupts a β5 Integrin Signaling Axis Controlling Anchorage-Independent Ovarian Carcinoma Growth
2023Open Access
Supplementary Figure 2 from FAK Inhibition Disrupts a β5 Integrin Signaling Axis Controlling Anchorage-Independent Ovarian Carcinoma Growth
2023Open Access
Supplementary Figure 5 from FAK Inhibition Disrupts a β5 Integrin Signaling Axis Controlling Anchorage-Independent Ovarian Carcinoma Growth
2023Open Access
Supplementary Figure 2 from FAK Inhibition Disrupts a β5 Integrin Signaling Axis Controlling Anchorage-Independent Ovarian Carcinoma Growth
2023Open Access
Supplementary Table 1 from FAK Inhibition Disrupts a β5 Integrin Signaling Axis Controlling Anchorage-Independent Ovarian Carcinoma Growth
2023Open Access
page 1 of 4Next →

Frequent Co-authors

David D. Schlaepfer(23), Xiao Lei Chen(19), Sean Uryu(19), Isabelle Tancioni(17), Nichol Miller(16), Christine Jean(15), Lee‐Hwa Tai(11), Kristy Ward(10), Florian J. Sulzmaier(9), Nina R. Shah(8), Ssang‐Taek Lim(5), Ali Akoum(5), Sara M. Weis(4), David A. Cheresh(4), Seyedeh-Raheleh Niavarani(4), Colin Walsh(3), Samuel G. Rouleau(3), Marie Boudaud(3), Elizabeth G. Kleinschmidt(3), Rodolphe Maheux(3)